全文获取类型
收费全文 | 3313篇 |
免费 | 330篇 |
国内免费 | 79篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 38篇 |
妇产科学 | 28篇 |
基础医学 | 382篇 |
口腔科学 | 28篇 |
临床医学 | 439篇 |
内科学 | 512篇 |
皮肤病学 | 36篇 |
神经病学 | 495篇 |
特种医学 | 36篇 |
外科学 | 426篇 |
综合类 | 164篇 |
预防医学 | 127篇 |
眼科学 | 75篇 |
药学 | 635篇 |
中国医学 | 144篇 |
肿瘤学 | 145篇 |
出版年
2024年 | 8篇 |
2023年 | 69篇 |
2022年 | 107篇 |
2021年 | 190篇 |
2020年 | 169篇 |
2019年 | 207篇 |
2018年 | 168篇 |
2017年 | 177篇 |
2016年 | 123篇 |
2015年 | 113篇 |
2014年 | 138篇 |
2013年 | 337篇 |
2012年 | 115篇 |
2011年 | 111篇 |
2010年 | 105篇 |
2009年 | 96篇 |
2008年 | 123篇 |
2007年 | 101篇 |
2006年 | 93篇 |
2005年 | 72篇 |
2004年 | 71篇 |
2003年 | 68篇 |
2002年 | 66篇 |
2001年 | 57篇 |
2000年 | 55篇 |
1999年 | 36篇 |
1998年 | 55篇 |
1997年 | 42篇 |
1996年 | 53篇 |
1995年 | 44篇 |
1994年 | 32篇 |
1993年 | 40篇 |
1992年 | 38篇 |
1991年 | 35篇 |
1990年 | 35篇 |
1989年 | 27篇 |
1988年 | 20篇 |
1987年 | 28篇 |
1986年 | 29篇 |
1985年 | 51篇 |
1984年 | 51篇 |
1983年 | 34篇 |
1982年 | 34篇 |
1981年 | 20篇 |
1980年 | 22篇 |
1979年 | 19篇 |
1978年 | 7篇 |
1977年 | 10篇 |
1976年 | 7篇 |
1974年 | 6篇 |
排序方式: 共有3722条查询结果,搜索用时 218 毫秒
1.
Mette Nissen Tiina‐Mari Ikheimo Jukka Huttunen Ville Leinonen Henna‐Kaisa Jyrkknen Mikael von und zu Fraunberg 《Neuromodulation》2021,24(1):102-111
ObjectiveSpinal cord stimulation (SCS) is an effective treatment in failed back surgery syndrome (FBSS). We studied the effect of preimplantation opioid use on SCS outcome and the effect of SCS on opioid use during a two-year follow-up period.Materials and methodsThe study cohort included 211 consecutive FBSS patients who underwent an SCS trial from January 1997 to March 2014. Participants were divided into groups, which were as follows: 1) SCS trial only (n = 47), 2) successful SCS (implanted and in use throughout the two-year follow-up period, n = 131), and 3) unsuccessful SCS (implanted but later explanted or revised due to inadequate pain relief, n = 29). Patients who underwent explantation for other reasons (n = 4) were excluded. Opioid purchase data from January 1995 to March 2016 were retrieved from national registries.ResultsHigher preimplantation opioid doses associated with unsuccessful SCS (ROC: AUC = 0.66, p = 0.009), with 35 morphine milligram equivalents (MME)/day as the optimal cutoff value. All opioids were discontinued in 23% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.004). Strong opioids were discontinued in 39% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.04). Mean opioid dose escalated from 18 ± 4 MME/day to 36 ± 6 MME/day with successful SCS and from 22 ± 8 MME/day to 82 ± 21 MME/day with unsuccessful SCS (p < 0.001).ConclusionsHigher preimplantation opioid doses were associated with SCS failure, suggesting the need for opioid tapering before implantation. With continuous SCS therapy and no explantation or revision due to inadequate pain relief, 39% of FBSS patients discontinued strong opioids, and 23% discontinued all opioids. This indicates that SCS should be considered before detrimental dose escalation. 相似文献
2.
3.
4.
《Cancer cell》2021,39(11):1497-1518.e11
- Download : Download high-res image (282KB)
- Download : Download full-size image
5.
《The Journal of arthroplasty》2020,35(11):3099-3107.e14
BackgroundPatients awaiting total joint arthroplasty (TJA) have high rates of opioid use, and many continue to use opioid medications long term after surgery. The objective of this study is to estimate the risk factors associated with chronic opioid use after TJA in a comprehensive population-based cohort.MethodsAll patients undergoing TJA in the New Zealand public healthcare system were identified from Ministry of Health records. Dispensing of opioid medications up to 3 years postsurgery and potential risk factors, including demographic, socioeconomic, and surgery-related characteristics, pre-existing medical comorbidities, and use of other analgesic medications prior to surgery, were identified from linked population databases. Logistic regression analysis was used to identify factors associated with chronic postoperative opioid use.ResultsThe strongest risk factor for chronic postoperative opioid use was preoperative opioid use. Other significant risk factors included perioperative opioid use, history of alcohol or drug abuse, younger age, female gender, knee arthroplasty, several comorbid health conditions, and preoperative use of some analgesic medications. Protective factors included higher education levels and preoperative use of nonsteroidal anti-inflammatory drugs. Most risk factors had similar effects on chronic postoperative opioid use irrespective of the length of follow-up considered (1, 2, or 3 years).ConclusionThis study of a comprehensive nationwide population-based cohort of TJA patients with 3 years of follow-up identified several modifiable risk factors and other easily measured patient characteristics associated with higher risk of long-term postoperative opioid use. 相似文献
6.
7.
8.
Acute Immobilization Stress and Intraventricular Injection of CRF Suppress Naloxone-Induced LH Release in Ovariectomized Estrogen-Primed Rats 总被引:1,自引:0,他引:1
Tatsuo Akema Atsuhiko Chiba Reiji Shinozaki Morihiro Oshida Fukuko Kimura & Jun-ichi Toyoda 《Journal of neuroendocrinology》1996,8(8):647-652
The present study was undertaken to evaluate the role and possible interaction of the endogenous opioid peptide (EOP) and corticotropin-releasing factor (CRF) in the acute stress-induced suppression of gonadotropin secretion in ovariectomized estrogen-primed rats. An intravenous (i.v.) injection of naloxone (10 or 20 mg/kg), an EOP antagonist, significantly elevated serum luteinizing hormone (LH) levels within 10 min in non-stressed animals. The naloxone-induced LH release was completely eliminated when tested 30 min after the onset of acute immobilization. In a subsequent study, it was found that suppression of the naloxone-induced LH release occurred as early as 5 min after the stress onset, and was still evident 60 min after the end of a 30-min period of immobilization. The effect of naloxone was restored 3 h after liberation of the animal from the 30-min immobilization. An intraventricular (i.c.v.) injection of CRF (1 or 5 μg) also significantly suppressed, in a dose-related manner, the effect of a subsequent i.v. injection of naloxone. However, an i.c.v. injection of α -helical CRF(9-41) (25 or 50 μg), a CRF antagonist, prior to immobilization, could not interfere with the suppressive effect of stress on naloxone-induced LH release. These results suggest that both acute immobilization stress and CRF can inhibit the LH secretory activity without mediation by EOP neurons. However, the stress-related suppression may involve non-CRF mechanism(s). 相似文献
9.
10.
This case report describes the anaesthetic management of a patient with sporadic-type long QT interval syndrome (LQTS), and increased QT dispersion, who presented for removal of an ovarian cyst. Beta adrenergic blockade and adequate depth of anaesthesia for successful management is emphasized. The Successful use of epidural administration of lignocaine and opioids in addition to general anaesthesia is described. 相似文献